Home > Analytics > NGL FINECHEM

NGL FINECHEM
Intrinsic Value | Fundamental Analysis

BOM : 524774     NSE : NGLFINE    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 07,2023
Price(EOD): ₹ 1,518.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 941.69 Cr
Value of ₹ 1 Lac invested in NGL FINECHEM
on Jun 07,2018 (price: ₹ 393.90)

₹ 1 L

₹ 3.86 L

1W : 1.7% 1M : 2.2% 1Y : -20.6%
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
NGL FINECHEM 1.7% 2.2% -20.6%
SUN PHARMACEUTICAL INDUSTRIES 2.7% 5.9% 17.9%
DIVIS LABORATORIES 0.5% 4.8% 0.3%
CIPLA -0.4% 2.3% -1.5%
DR REDDYS LABORATORIES 2.6% -5.3% 7%
TORRENT PHARMACEUTICALS 1.5% 9.3% 27.1%
ABBOTT INDIA 1.3% -0.2% 18.8%
ZYDUS LIFESCIENCES 0.3% -1.9% 41.3%
ALKEM LABORATORIES 0.8% -5.8% 9.5%

FUNDAMENTAL ANALYSIS OF NGL FINECHEM

 
Fundamentals Score
[ Q(TTM): Mar2023, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF NGL FINECHEM

 
Valuation Score
[As on : Jun 07,2023 ]

Ratio Consolidated
P/E
P/B
P/S
44.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 21.00 Cr
[Latest Qtr - Mar2023 - Consolidated Results ]

4.22
P/B Calculated based on Book Value of Rs 222.55 Cr
[Latest Year - Mar2023 - Consolidated Results ]

3.37
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 278.15 Cr
[Latest Qtr - Mar2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF NGL FINECHEM

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
323%
603%
592%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NGL FINECHEM



NGL FINECHEM vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NGL FINECHEM

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.15
0.11
0.28
0.18
0.15
0.11
0.29
0.18
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NGL FINECHEM

Pledged Promoter Shares
0 %
As on : Mar2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NGL FINECHEM

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
2.72%
32.2%
33.75%
43.77%
-12.1%
22.82%
41.37%
35.81%
QtrlyTrend
6
Latest Qtr: Mar2023
Quarterly Result Analysis →


NGL FINECHEM related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 3.3% 7.1% 18.8%
S&P BSE HEALTHCARE 3.2% 5.1% 10%
S&P BSE MIDSMALLCAP 2.9% 6.7% 19.4%
S&P BSE ALLCAP 1.6% 3.9% 13.8%
No NSE index found

You may also like the below Video Courses


FAQ about NGL FINECHEM


Is NGL FINECHEM good for long term investment?

As on Jun 07,2023, the Fundamentals of NGL FINECHEM look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NGL FINECHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NGL FINECHEM UnderValued or OverValued?

As on Jun 07,2023, NGL FINECHEM is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NGL FINECHEM ?

As on Jun 07,2023, the Intrinsic Value of NGL FINECHEM is Rs. 219.38 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 358.93
Fair Value [Median EV / Sales Model] : Rs. 216.02
Fair Value [Median Price / Sales Model] : Rs. 219.38
Estimated Median Fair Value of NGL FINECHEM : Rs. 219.38

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is NGL FINECHEM trading at a Premium or Discount?

As on Jun 07,2023, NGL FINECHEM is trading at a Premium of 592% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].